Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All SelectQuote, Inc. filings on SEC EDGAR ↗
SelectQuote, Inc. announced a 1-for-20 reverse stock split of its common stock, effective November 16, 2026, following stockholder approval at its annual meeting. The split is intended to increase the per-share trading price to regain compliance with the NYSE's minimum bid price requirement. The total number of authorized shares will also be reduced proportionately from 700 million to 35 million.
SelectQuote Insider Raymond F. Weldon Buys $201K of Stock
Raymond F. Weldon bought 409,836 shares of SelectQuote, Inc. at $0.49 a share, worth $201K in total on Nov 6, 2026. Shares held after the trade: 923,050 (+79.9%).
SelectQuote COO William Thomas Grant III Buys $40.2K of Stock
William Thomas Grant III, COO, bought 79,600 shares of SelectQuote, Inc. at $0.505 a share, worth $40.2K in total on Nov 6, 2026. Shares held after the trade: 3,468,094 (+2.3%).
SelectQuote Insider Donald L. Hawks III Buys $114K of Stock
Donald L. Hawks III bought 250,000 shares of SelectQuote, Inc. at $0.439 to $0.459 a share (average $0.4569) in 2 transactions, worth $114K in total between Nov 6, 2026 and Nov 9, 2026. Shares held after the trade: 763,214 (+41.4%).
SelectQuote President Robert Clay Grant Buys $40.3K of Stock
Robert Clay Grant, President, bought 79,801 shares of SelectQuote, Inc. at $0.505 a share, worth $40.3K in total on Nov 6, 2026. Shares held after the trade: 3,386,491 (+2.4%).
SelectQuote CEO Timothy Robert Danker Buys $50.7K of Stock
Timothy Robert Danker, CEO, bought 100,668 shares of SelectQuote, Inc. at $0.504 a share, worth $50.7K in total on Nov 6, 2026. Shares held after the trade: 3,076,073 (+3.4%).
SelectQuote outperformed EBITDA and cash flow expectations despite a 15% revenue decline, pivoting to a profitability-first strategy through AI-driven efficiency and healthcare services margin expansion.
SelectQuote reported a net loss of $20.3 million for the quarter ended September 30, 2026, an improvement from the $30.5 million loss in the prior year. Total revenue decreased to $280.0 million from $328.8 million, driven by declines in both pharmacy and commission-based services.
SelectQuote reported first quarter fiscal 2027 revenue of $280.0 million and a net loss of $20.3 million, showing a year-over-year improvement in Adjusted EBITDA and operating cash flow. The company reaffirmed its full-year fiscal 2027 guidance, expecting revenue between $1.35 billion and $1.45 billion and operating cash flow exceeding $60 million.
Term
Q1 2027
“We are proud of another strong quarter across both our Senior and Healthcare Services segments, resulting in a material year-over-year improvement in adjusted EBITDA and operating cash flow. We have high confidence in our current and long-term strategy to drive value for stakeholders, and we are pleased to reiterate our full-year financial targets for fiscal 2027.”
Tim Danker, SelectQuote’s Chief Executive Officer
“SelectQuote’s performance, in our seasonally slowest quarter, showcases the continued impact of our strategy to optimize profitability and cash flow. Despite lower revenue across both Senior and Healthcare Services, SelectQuote drove a 30% improvement in our year-over-year trailing twelve month adjusted EBITDA, and we remain on track to drive over $60 million in operating cash flow in fiscal 2027.”